Literature DB >> 8194199

Heterogeneities of attachment, chemotaxis, and protease production among clones with different metastatic potentials from a human pancreatic cancer cell line.

S Taniguchi1, T Iwamura, N Kitamura, H Yamanari, T Setoguchi.   

Abstract

The present study extends our investigations into the metastatic heterogeneity among four clonal cell lines (S2-007:H, S2-013:M1, S2-020:M2, and S2-028:L) from a human pancreatic cancer cell line (SUIT-2), and extends our discussion the positive correlation between metastatic potential and the type I collagenase activity of the cells, focusing on their interaction with extracellular matrix. Ability to attach to the reconstituted basement membrane (Matrigel) was higher for clone H than clone L during an observation period of 30-60 min, whereas clones M1 and M2 were found to be intermediate in ability. In densitometric and radioactive studies, clone L exhibited the lowest collagenolytic activity against mouse and human type IV collagen, while clone H exhibited the highest activity in the densitometric study and clone M1 was the highest in the radioactive study. The production of urinary-type plasminogen activator was highest in clone L and lowest in clone H. On the other hand, tissue-type plasminogen activator was highest in clone M2 and low in both clones H and L. Clone M2 exhibited the highest chemotactic activity toward diluted Matrigel, whereas clone L had the lowest activity. On the whole, these clones showed heterogenous interactions with an extracellular matrix. It is suggested that the attachment activity to basement membrane and the type IV collagenolytic activity of the cells may be positively correlated with their metastatic potential, whereas the production of urinary-type plasminogen activator was negatively correlated, but confirmation of these findings awaits further study.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8194199     DOI: 10.1007/bf01753892

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  22 in total

1.  High invasiveness associated with augmentation of motility in a fos-transferred highly metastatic rat 3Y1 cell line.

Authors:  S Taniguchi; M Tatsuka; K Nakamatsu; M Inoue; H Sadano; H Okazaki; H Iwamoto; T Baba
Journal:  Cancer Res       Date:  1989-12-01       Impact factor: 12.701

2.  Basement membrane type IV collagen degradation: evidence for the involvement of a proteolytic cascade independent of metalloproteinases.

Authors:  A R Mackay; R H Corbitt; J L Hartzler; U P Thorgeirsson
Journal:  Cancer Res       Date:  1990-09-15       Impact factor: 12.701

Review 3.  Basement membrane and the invasive activity of metastatic tumor cells.

Authors:  V P Terranova; E S Hujanen; G R Martin
Journal:  J Natl Cancer Inst       Date:  1986-08       Impact factor: 13.506

4.  Involvement of plasminogen activator production with tumor metastasis in a rat model.

Authors:  S A Carlsen; I A Ramshaw; R C Warrington
Journal:  Cancer Res       Date:  1984-07       Impact factor: 12.701

5.  Activation of human breast carcinoma collagenase through plasminogen activator.

Authors:  M Paranjpe; L Engel; N Young; L A Liotta
Journal:  Life Sci       Date:  1980-04-14       Impact factor: 5.037

6.  The selection and characterization of an invasive variant of the B16 melanoma.

Authors:  I R Hart
Journal:  Am J Pathol       Date:  1979-12       Impact factor: 4.307

7.  The in vitro invasiveness and interactions with laminin of K-1735 melanoma cells. Evidence for different laminin-binding affinities in high and low metastatic variants.

Authors:  A Albini; S L Aukerman; R C Ogle; D M Noonan; R Fridman; G R Martin; I J Fidler
Journal:  Clin Exp Metastasis       Date:  1989 Jul-Aug       Impact factor: 5.150

8.  Comparative study of plasminogen activators in cancers and normal mucosae of human urinary bladder.

Authors:  Y Hasui; J Suzumiya; K Marutsuka; A Sumiyoshi; S Hashida; E Ishikawa
Journal:  Cancer Res       Date:  1989-02-15       Impact factor: 12.701

9.  Rat mammary carcinoma cells secrete active collagenase and activate latent enzyme in the stroma via plasminogen activator.

Authors:  R L O'Grady; L I Upfold; R W Stephens
Journal:  Int J Cancer       Date:  1981-10-15       Impact factor: 7.396

10.  A study of proteases and protease-inhibitor complexes in biological fluids.

Authors:  A Granelli-Piperno; E Reich
Journal:  J Exp Med       Date:  1978-07-01       Impact factor: 14.307

View more
  6 in total

1.  Effects of Taxotere on invasive potential and multidrug resistance phenotype in pancreatic carcinoma cell line SUIT-2.

Authors:  B Liu; E Staren; T Iwamura; H Appert; J Howard
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

2.  Genistein-stimulated adherence of prostate cancer cells is associated with the binding of focal adhesion kinase to beta-1-integrin.

Authors:  R Bergan; E Kyle; P Nguyen; J Trepel; C Ingui; L Neckers
Journal:  Clin Exp Metastasis       Date:  1996-09       Impact factor: 5.150

3.  High collagenolytic activity in spontaneously highly metastatic variants derived from a human pancreatic cancer cell line (SUIT-2) in nude mice.

Authors:  N Kitamura; T Iwamura; S Taniguchi; H Yamanari; M A Kawano; K Hollingsworth; T Setoguchi
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

4.  Beta 2-microglobulin regulates amyloid precursor-like protein 2 expression and the migration of pancreatic cancer cells.

Authors:  Bailee H Sliker; Benjamin T Goetz; Haley L Peters; Brittany J Poelaert; Gloria E O Borgstahl; Joyce C Solheim
Journal:  Cancer Biol Ther       Date:  2019-02-27       Impact factor: 4.742

5.  Cancer cell motility: optimizing spatial search strategies.

Authors:  L Leon Chen; Le Zhang; Jeongah Yoon; Thomas S Deisboeck
Journal:  Biosystems       Date:  2008-11-14       Impact factor: 1.973

6.  HLA-B influences integrin beta-1 expression and pancreatic cancer cell migration.

Authors:  Bailee H Sliker; Benjamin T Goetz; Raina Barnes; Hannah King; H Carlo Maurer; Kenneth P Olive; Joyce C Solheim
Journal:  Exp Cell Res       Date:  2020-03-16       Impact factor: 3.905

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.